CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea
Heterologous approach aims to deliver targeted, broad-spectrum immune response to Neisseria gonorrhoeae infections BOSTON, April 28, 2026 /PRNewswire/ — Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$2.6 million to AdJane to
